Tumor immunotherapy has rapidly emerged as a cornerstone in oncology, revolutionizing the treatment landscape for patients with advanced malignancies.

Immunotherapy in particular, she said, could mean the difference between relapse and survival. Kiu said SCCS supported ...

Fred Hutch researchers launch free online tool to assess colorectal cancer risk Researchers led by Ulrike “Riki” Peters, PhD, MPH, holder of the 40th Anniversary Endowed Chair, and Li Hsu, PhD, ...

Chimeric antigen receptor natural killer (CAR-NK) cell therapy is emerging as a promising next-generation immunotherapy with ...

New York, United States, January 7th, 2026, FinanceWireGlobal investment management leader Aurum Capital has announced the ...

A protein that produces hydrogen sulfide may be a new therapeutic target, as its deficiency is linked to cognitive deficits ...

Elephas Biosciences Corporation (Elephas), a privately held leader in precision oncology, today announced the publication of a foundational paper in Journal of Translational Medicine. The paper ...

New Medicaid eligibility rules may cause more than a million missed cancer screenings, and more than 100 preventable deaths, ...

Jonathan Bricker, PhD, and Fred Hutch’s Health and Behavioral Innovations in Technology (HABIT) research group developed an AI-powered chatbot app called QuitBot to help more people successfully quit ...

The poster, presented by William Audeh, MD, MS, chief medical officer of Agendia, cited results from the MammaPrint, ...

Lehi Utah, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Lehi, Utah, January 7, 2026 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to ...

Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...